LCN2 and Alzheimer disease: IgG and Fibrinogen immunoreactivity was detected in the perivascular space in AD and VaD, but not in controls (Supplementary Fig. 3), suggesting BBB impairment in both diseases and the absence of differential contribution of BBB alteration to the CSF concentrations of LCN2 in AD and VaD.